Financials Nanjing Medlander Medical Technology Co.,Ltd.
Equities
688273
CNE100005PV8
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.47 CNY | -1.72% | -2.05% | -29.54% |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 3,260 | 2,347 | 2,347 | - |
Enterprise Value (EV) 1 | 3,260 | 3,352 | 2,347 | 2,347 |
P/E ratio | 22 x | 37.1 x | 14.1 x | 10.2 x |
Yield | - | 1.8% | 2.56% | 2.77% |
Capitalization / Revenue | - | 9.83 x | 4.13 x | 3.25 x |
EV / Revenue | - | 9.83 x | 4.13 x | 3.25 x |
EV / EBITDA | - | 28.4 x | 11.8 x | 8.53 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | 2.49 x | 1.6 x | 1.43 x |
Nbr of stocks (in thousands) | 100,000 | 100,000 | 100,000 | - |
Reference price 2 | 32.60 | 23.47 | 23.47 | 23.47 |
Announcement Date | 2/26/23 | 2/23/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | 340.8 | 568 | 722 |
EBITDA 1 | - | 118 | 199 | 275 |
EBIT 1 | - | 102.5 | 199 | 270 |
Operating Margin | - | 30.07% | 35.04% | 37.4% |
Earnings before Tax (EBT) 1 | - | 101.5 | 199 | 270 |
Net income 1 | 123 | 89.82 | 168 | 231 |
Net margin | - | 26.35% | 29.58% | 31.99% |
EPS 2 | 1.480 | 0.8982 | 1.670 | 2.300 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share 2 | - | 0.6000 | 0.6000 | 0.6500 |
Announcement Date | 2/26/23 | 2/23/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt | - | - | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | 6.63% | 11.4% | 14% |
ROA (Net income/ Total Assets) | - | 5.8% | 10% | 12.2% |
Assets 1 | - | 1,549 | 1,680 | 1,893 |
Book Value Per Share 2 | - | 13.40 | 14.70 | 16.40 |
Cash Flow per Share 2 | - | 1.360 | 1.660 | 2.950 |
Capex 1 | - | 74.6 | 11 | 11 |
Capex / Sales | - | 21.88% | 1.94% | 1.52% |
Announcement Date | 2/26/23 | 2/23/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.54% | 324M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- 688273 Stock
- Financials Nanjing Medlander Medical Technology Co.,Ltd.